NOTICE: This Consumer Medicine Information (CMI) is intended for persons
Tethering together type 2 diabetes drugs increases efficacy of combination therapy
Biomedical engineers at Duke University have shown that the efficacy
New compound could enhance the efficacy of standard breast cancer treatment
A novel compound against breast cancer improves the efficacy of
Monitoring Movement Reflects Efficacy of Mandibular Splint
THURSDAY, Nov. 29, 2018 — For individuals with obstructive sleep
No Efficacy Signal for Fluoxetine in EV-D68 Acute Flaccid Myelitis
TUESDAY, Nov. 13, 2018 — The antiviral agent fluoxetine is
Deciphera Pharmaceuticals Initiates a Phase 1b/2 Clinical Trial of Rebastinib in Combination with Paclitaxel to Assess Safety, Tolerability, Pharmacokinetics and Efficacy in Patients with Advanced or Metastatic Solid Tumors
WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 23, 2018– Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a
KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD
CORALVILLE, Iowa, July 09, 2018 (GLOBE NEWSWIRE) — KemPharm, Inc.